CVS Health Corporation (cvs)
CVS — Company Overview
CVS Health Corporation (CVS) is a large-cap company in the Healthcare sector, operating in Healthcare Plans.
| Ticker | CVS |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Exchange | NYQ |
| Market cap | $123.06B |
| Last price | $96.22 |
| Size category | Large Cap |
CVS — Business Description
CVS Health Corporation (CVS) operates in Healthcare Plans within the broader Healthcare market. CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including…
Official website: https://www.cvshealth.com.
CVS — Investment Thesis
The investment thesis for CVS Health Corporation (CVS) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 7.1% year-over-year (public data).
- Trailing P/E of 26.15× sits in a moderate band relative to high-growth peers.
- Forward P/E (11.37×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 2.7% adds an income component to total return.
- Equity market capitalization is approximately $123.06B.
Analyst consensus, price targets & estimates is available in Vest Terminal for Professional and Enterprise subscribers.
CVS — Financial Health
Financial health for CVS Health Corporation (CVS) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin near 1.2% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $8.08B supports balance-sheet flexibility.
| Trailing P/E | 26.15× |
| Forward P/E | 11.37× |
| Price / Sales | 0.30× |
| Price / Book | 1.54× |
| Gross margin | 13.6% |
| Operating margin | 3.9% |
| Profit margin | 1.2% |
| Return on equity | 6.2% |
| Debt / Equity | 95.50 |
| Free cash flow | $8.08B |
CVS — Growth Outlook
Growth outlook for CVS Health Corporation (CVS) depends on demand trends in Healthcare Plans and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 7.1% suggests steady but measured expansion.
- Earnings growth of 1.9% year-over-year supports improving profitability.
- Price is 13.1% below the 52-week high.
CVS — Competitive Position
CVS Health Corporation (CVS) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Healthcare Plans.
- Market capitalization of $123.06B places CVS among large-cap peers.
- Gross margin of 13.6% should be benchmarked against direct competitors.
CVS — Strengths
Strengths for CVS Health Corporation (CVS) inferred from public financial metrics:
- Revenue growth of 7.1% year-over-year.
- Earnings growth of 1.9% year-over-year.
- Positive free cash flow ($8.08B).
- Dividend yield of 2.7% for income-oriented holders.
- Large Cap scale ($123.06B) may provide distribution and funding advantages.
CVS — Weaknesses
Weaknesses and pressure points for CVS Health Corporation (CVS) based on available data:
- Thin profit margin (1.2%).
CVS — Opportunities
- Dividend yield of 2.7% appeals to total-return investors.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
CVS — Risks
- Thin margins leave less room for operational missteps.
CVS — Summary
CVS Health Corporation (CVS) is a large-cap Healthcare company focused on Healthcare Plans, listed on NYQ. Last price $96.22 with market cap $123.06B. Trailing P/E 26.15×. Revenue grew 7.1% year-over-year per public data. Notable strengths include revenue growth of 7.1% year-over-year. Key watch items include thin profit margin (1.2%). Detailed estimates, ownership, and news for CVS Health Corporation remain locked in Vest Terminal for subscribers.
CVS Health Corporation FAQ
What does CVS Health Corporation (CVS) do?
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical…
What is CVS's P/E ratio?
CVS Health Corporation has a trailing P/E of 26.15× based on publicly available market data.
Does CVS pay a dividend?
Indicated dividend yield: 2.7%. Confirm ex-dates and payout history in Vest Terminal.
What sector is CVS in?
CVS Health Corporation is classified in Healthcare (Healthcare Plans) on NYQ.
What is CVS's market capitalization?
Approximate market cap: $123.06B.
What are the main risks for CVS?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of CVS?
Potential positives include revenue growth of 7.1% year-over-year, earnings growth of 1.9% year-over-year.
Where can I get analyst estimates for CVS?
Consensus estimates, price targets, and detailed analyst data for CVS Health Corporation are available to Professional subscribers in Vest Terminal — not on this public summary page.